Table 2.
Parameters, values, and sources used in pre-eclampsia decision tree analysis
| Parameter Description | Value | Source |
|---|---|---|
| % of pregnancies that are pre-eclamptic | 2.80% | WHO Global Survey on maternal and perinatal health 2009 [34] |
| % of pregnancies tested for pre-eclampsia | 51.00% | WHO Global Health Observatory [35] |
| Survival rate for undiagnosed or untreated pre-eclampsia | 94.40% | Prual, 2000 [15] |
| % of diagnosed pre-eclampsia treated | 16.00% | Varies worldwide; Dr. Johnson |
| Success rate of treatment among pre-eclamptic pregnancies | 99.20% | The Magpie Trial Collaborative Group [5] |
| Survival rate for successfully treated pre-eclamptic pregnancies | 99.43% | World Health Statistics 2011 [36]; Dr. Martin |
| Survival rate for unsuccessfully treated pre-eclamptic pregnancies | 94.40% | Prual, 2000 [15]; Dr. Martin |
| Rate of severe complications for pre-eclampsia survivors | 3.80% | Sibai, 2005 [4], Steeger, 2010 [37] |
| HRQL for lifetime following severe complications | 0.25 | Lee et al., 2010, Aberg et al. (2011), WHO (2004) [18–20] |
| Life expectancy | 55 yrs | |
| Discount rate | 3% |